Compare · GMED vs OFIX
GMED vs OFIX
Side-by-side comparison of Globus Medical Inc. (GMED) and Orthofix Medical Inc. (OFIX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GMED and OFIX operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- GMED is the larger of the two at $9.34B, about 34.7x OFIX ($269.4M).
- GMED has been more active in the news (9 items in the past 4 weeks vs 8 for OFIX).
- GMED has more recent analyst coverage (25 ratings vs 10 for OFIX).
- Company
- Globus Medical Inc.
- Orthofix Medical Inc.
- Price
- -
- -
- Market cap
- $9.34B
- $269.4M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2012
- 1992
- News (4w)
- 9
- 8
- Recent ratings
- 25
- 10
Globus Medical Inc.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Orthofix Medical Inc.
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Extremities. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Global Extremities segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Latest GMED
- Director Tobin James R exercised 41,666 shares at a strike of $56.30 and sold $3,131,547 worth of shares (41,666 units at $75.16) (SEC Form 4)
- SEC Form 144 filed by Globus Medical Inc.
- Globus Medical to Participate in Jefferies Global Healthcare Conference
- Globus Medical downgraded by BMO Capital Markets with a new price target
- Director Rhoads Ann D sold $425,000 worth of shares (5,000 units at $85.00) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 35,384 units (SEC Form 4)
- SEC Form 10-Q filed by Globus Medical Inc.
- Globus Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program
- Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
- Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Latest OFIX
- SEC Form SCHEDULE 13G filed by Orthofix Medical Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Orthofix Medical Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Orthofix Medical Inc.
- Large owner Juniper Investment Company, Llc bought $5,106,709 worth of shares (689,803 units at $7.40) (SEC Form 4)
- SEC Form 10-Q filed by Orthofix Medical Inc.
- Orthofix Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance
- President, Global Limb Recon Fisher Patrick sold $1,360 worth of shares (150 units at $9.07) as part of a pre-agreed trading plan, decreasing direct ownership by 0.29% to 50,769 units (SEC Form 4)
- Orthofix to Report Third Quarter 2026 Financial Results
- President, Global Limb Recon Fisher Patrick sold $1,416 worth of shares (150 units at $9.44) as part of a pre-agreed trading plan (SEC Form 4)